Perioperative Pain Management
Post-surgical pain, specifically for Total Knee Arthroplasty (TKA)
CommercialActive
Key Facts
Indication
Post-surgical pain, specifically for Total Knee Arthroplasty (TKA)
Phase
Commercial
Status
Active
Company
About iovera
iovera° is a commercial-stage medical device company focused on non-opioid pain management through its cryoneurolysis platform. Its flagship iovera° system is FDA-cleared for blocking peripheral nerves to relieve pain for up to 90 days, with primary applications in osteoarthritis knee pain and perioperative pain management for procedures like knee replacement surgery. The company targets the significant unmet need for effective, non-pharmacological pain relief solutions amid the opioid crisis. As a private company, it commercializes its device directly to healthcare professionals in outpatient settings.
View full company profile